Key Metrics
Factor Lens
Seasonal Performance
Dividends
Per-share amounts adjusted for stock splits.
Last 12 Payouts
| Period | Ex-Date | Amount / Share |
|---|---|---|
| ANNC | 2026-08-19 | $0.6600 |
| Q3 2026 | 2026-05-13 | $0.6000 |
| Q4 2025 | ~2026-04-01 | $0.6700 |
| Q2 2025 | 2026-02-11 | $0.6000 |
| Q1 2025 | 2025-11-12 | $0.6000 |
| Q1 2025 | 2025-08-13 | $0.6000 |
| Q3 2025 | 2025-05-07 | $0.5300 |
| Q4 2024 | ~2025-04-01 | $0.5800 |
| Q2 2024 | 2025-02-12 | $0.5300 |
| Q1 2024 | 2024-11-06 | $0.5300 |
| Q1 2024 | 2024-08-14 | $0.5300 |
| Q3 2024 | 2024-05-08 | $0.4800 |
Financial Trends
Revenue & Net Income
Earnings Per Share
Margins
Cash Flow
Company Overview
ResMed Inc. is a global leader in digital health and cloud-connected medical devices. The company designs innovative technology to empower people to live happier, healthier lives.… ResMed's artificial intelligence-powered digital health solutions, cloud-connected devices and intelligent software are designed to make home healthcare more personalized, accessible and effective. The company operates in two segments: Sleep and Breathing Health and Residential Care Software. The Sleep and Breathing Health segment includes devices and masks designed to treat obstructive sleep apnea, chronic obstructive pulmonary disease, and other sleep and breathing health conditions, along with AI-powered digital solutions. The Residential Care Software segment provides cloud-based health applications and software for residential care settings. ResMed sells its products in more than 140 countries through wholly owned subsidiaries and independent distributors. In June 2026, the company acquired Noctrix Health, which treats restless legs syndrome, expanding its clinical sleep health portfolio. The company also operates VirtuOx, acquired in 2025, which provides technology solutions for in-home and remote testing services for sleep, respiratory, cardiac, and other health conditions.
- Name
- ResMed Inc.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Michael Farrell · Chairman of the Board and Chief Executive Officer
- Employees
- 11,370 as of 2026-06-30
- IPO Date
- 2018-05-04
- Phone
- (858) 836-5000
- Address
- 9001 Spectrum Center Blvd., San Diego, CA 92123
- Website
- www.resmed.com
Key Executives
| Name | Title | FY Pay |
|---|---|---|
| Aaron Bloomer | Chief Financial Officer | — |
| Michael "Mick" Farrell | Chairman of the Board and Chief Executive Officer | — |
Latest News
- 2026-04-26
- 2026-04-23
- 2026-04-23
- 2026-04-20
-
2026-04-18
Lbp Am Sa Buys 18,142 Shares of ResMed Inc. $RMD defenseworld.net
- 2026-04-17
-
2026-04-11
Michael Farrell Sells 4,991 Shares of ResMed (NYSE:RMD) Stock defenseworld.net
-
2026-04-10
Aaron Wealth Advisors LLC Sells 2,210 Shares of ResMed Inc. $RMD defenseworld.net